Tezspire approved in Japan for the treatment of severe asthma
Tezspire approved for a broad population of patients with severe asthma with no phenotype or biomarker limitations AstraZeneca’s Tezspire( tezepelumab) has been approved in Japan…
Category Uncategorized
Read More